Beneficial effect of carvone, a dietary monoterpene ameliorates hyperglycemia by regulating the key enzymes activities of carbohydrate metabolism in streptozotocin-induced diabetic rats

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 1558-1567

  Muruganathan, Udaiyar ^a   Srinivasan, Subramani ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Carbohydrate metabolic enzymes; Carvone; Diabetes mellitus; Glucose; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CARVONE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIVER ENZYME; STREPTOZOCIN; ANTIOXIDANT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; LIVER TISSUE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TISSUE; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; BODY WEIGHT; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DRINKING BEHAVIOR; DRUG EFFECTS; ENZYMOLOGY; FEEDING BEHAVIOR; HYPERGLYCEMIA; LIVER; METABOLISM; PANCREAS; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DRINKING BEHAVIOR; FEEDING BEHAVIOR; GLYCOGEN; HEMOGLOBIN A, GLYCOSYLATED; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; LIVER; MALE; MONOTERPENES; PANCREAS; RATS, WISTAR; STREPTOZOCIN;

EID: 85001130080     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.11.025     Document Type: Article

References (44)

1. [1] Marella, S., Maddirela, D.R., Kumar, E.G., Tilak, T.K., Badri, K.R., Chippada, A., Mcy protein, a potential antidiabetic agent: evaluation of carbohydrate metabolic enzymes and antioxidant status. Int. J. Biol. Macromol. 86 (2016), 481–488.
2. [2] Kuricova, K., Pacal, L., Soupal, J., Prazny, M., Kankova, K., Effect of glucose variability on pathways associated with glucotoxicity in diabetes: evaluation of a novel in vitro experimental approach. Diabetes Res. Clin. Pract. 114 (2016), 1–8.
3. [3] IDF Diabetes Atlas Group, Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res. Clin. Pract. 109 (2015), 461–465.
4. [4] Varadarajan, P., Infantile onset diabetes mellitus in developing countries—India. World J. Diabetes 7 (2016), 134–141.
5. [5] Grewal, A.S., Sekhon, B.S., Lather, V., Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus. Mini Rev. Med. Chem. 14 (2014), 585–602.
6. [6] Hung, H.Y., Qian, K., Morris-Natschke, S.L., Hsu, C.S., Lee, K.H., Recent discovery of plant-derived anti-diabetic natural products. Nat. Prod. Rep. 29 (2012), 580–606.
7. [7] Khalaf, R.A., Exploring natural products as a source for antidiabetic lead compounds and possible lead optimization. Curr. Top. Med. Chem. 16 (2016), 2549–2561.
8. [8] Carvalho, C.C.C.R., Da Fonseca, M.M.R., Carvone: why and how should one bother to produce this terpene. Food Chem. 95 (2006), 413–422.
9. [9] Farag, R.S., Daw, Z.Y., Abo-Raya, S.H., Influence of some spice essential oils on Aspergilrus pamsiticus growth and production of aflatoxin in a synthetic medium. J. Food Sci. 54 (1989), 74–76.
10. [10] Saxena, D.B., Goswami, B.K., Tomar, S.S., Nematitidal activity of some essential oils against Meloidogyne incognita. Indian Perfumer 31 (1987), 150–154.
11. [11] Zheng, G.Q., Kenney, P.M., Lam, L.K.T., Planta Med Serum carotenoids and atherosclerosis: the Rotterdam study. Atherosclerosis 338 (1992), 148–156.
12. [12] Johri, R.K., Cuminumcyminum and Carumcarvi: an update. Pharmacogn. Rev. 5 (2011), 63–72.
13. [13] Trinder, P., Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem., 6, 1969, 24.
14. [14] Burgi, W., Briner, M., Franken, N., Kessler, A.C., One-steps and wich enzyme immunoassay for insulin using monoclonal antibodies. Clin. Biochem. 21 (1998), 311–314.
15. [15] Bisse, E., Abragam, E.C., New less temperature sensitive, micro chromatographic method for the separation and quantitation of glycosylated haemoglobin using a non-cyanide buffer system. J. Chromatogr. 344 (1999), 81–91.
16. [16] Brandstrup, N., Kirk, J.E., Bruni, C., The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol. 12 (1957), 166–171.
17. [17] Bergmeyer, H.U., Glucose-6-Phosphate Dehydrogenase: Methods of Enzymatic Analysis, vol. 2, 1984, Verlag Chemie, Weinheim, Germany, 222–223.
18. [18] Koide, H., Oda, T., Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin. Chim. Acta 4 (1959), 554–561.
19. [19] Dziewulska-Szwajkowska, D., Lozinska-Gabska, M., Dzugaj, A., Rana esculenta L. liver Fru-1,6-P2ase and G-6-pase activity and Fru-2,6-P2 concentration after acclimation at 5 and 25 degrees C. Comp. Biochem. Physiol. 118 (1997), 745–751.
20. [20] Ong, K.C., Khoo, H.E., Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci. 67 (2000), 1695–1705.
21. [21] Misra, H.P., Fridovich, I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247 (1972), 3170–3175.
22. [22] Takahara, S., Hamilton, H.B., Neel, J.V., Kobara, T.Y., Ogura, Y., Nishimura, E.T., Hypocatalasemia: a new genetic carrier state. J. Clin. Invest. 39 (1960), 610–619.
23. [23] Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G., Hoekstra, W.G., Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973), 588–590.
24. [24] Habig, W.H., Pabst, M.J., Jakoby, W.B., Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974), 7130–7139.
25. [25] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
26. [26] Duncan, B.D., Multiple ranges tests for correlated and heteroscedastic means. Biometrics 13 (1957), 359–364.
27. [27] Cryer, P.E., Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63 (2014), 2188–2195.
28. [28] Muruganathan, U., Srinivasan, S., Indumathi, D., Antihyperglycemic effect of carvone: effect on the levels of glycoprotein components in streptozotocin-induced diabetic rats. JAD 2 (2013), 310–315.
29. [29] Kalyani, R.R., Corriere, M., Ferrucci, L., Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 14 (2014), 70034–70038.
30. [30] Solvik, U.O., Roraas, T., Christensen, N.G., Sandberg, S., Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices. Clin. Chem. 59 (2013), 1790–1801.
31. [31] Lu, M., Li, P., Bandyopadhyay, G., Lagakos, W., Dewolf, W.E. Jr., Alford, T., Chicarelli, M.J., Williams, L., Anderson, D.A., Baer, B.R., McVean, M., Conn, M., Véniant, M.M., Coward, P., Characterization of a novel glucokinase activator in rat and mouse models. PLoS One, 9, 2014, 88431.
32. [32] Heymann, A.D., Cohen, Y., Chodick, G., Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes. Diabetes Care 8 (2012), 35–58.
33. [33] Huang, D.W., Chang, W.C., Wu, J.S., Shih, R.W., Shen, S.C., Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet. Nutr. Res. 36 (2016), 150–160.
34. [34] Stanton, R.C., Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64 (2012), 362–369.
35. [35] Chen, R., Meseck, M., McEvoy, R.C., Woo, S.L., Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Ther. 7 (2000), 1802–1809.
36. [36] Abdel-Sattar, E., El-Maraghy, S.A., El-Dine, R.S., Rizk, S.M., Russelioside B a pregnane glycoside ameliorates hyperglycemia in streptozotocin induced diabetic rats by regulating key enzymes of glucose metabolism. Chem. Biol. Interact. 252 (2016), 47–53.
37. [37] Zhang, Y., Xie, Z., Zhou, G., Zhang, H., Lu, J., Zhang, W.J., Fructose-1,6-bisphosphatase regulates glucose-stimulated insulin secretion of mouse pancreatic beta-cells. Endocrinology 151 (2010), 4688–4695.
38. [38] Dervisevik, M., Dinevska-Kovkarovska, S., Dimitrovska, M., Cipanovska, N., Miova, B., High dose of aspirin moderates diabetes-induced changes of heart glycogen/glucose metabolism in rats. J. Physiol. Sci. 64 (2014), 411–420.
39. [39] Attanayake, A.P., Jayatilaka, K.A., Pathirana, C., Mudduwa, L.K., Gmelina arborea Roxb. (Family: Verbenaceae) extract upregulates the β-cell regeneration in STZ induced diabetic rats. J. Diabetes Res., 2016, 2016, 4513871.
40. [40] Kaya-Dagistanli, F., Ozturk, M., The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats. Acta Histochem. 115 (2013), 577–586.
41. [41] Kalailingam, P., Kannaian, B., Tamilmani, E., Kaliaperumal, R., Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats. Phytomedicine 21 (2014), 1154–1161.
42. [42] Luo, X., Wu, J., Jing, S., Yan, L.J., Hyperglycemic stress and carbon stress in diabetic glucotoxicity. Aging Dis. 7 (2016), 90–110.
43. [43] Vinothkumar, R., Sudha, M., Viswanathan, P., Kabalimoorthy, J., Balasubramanian, T., Nalini, N., Modulating effect of d-carvone on 1,2-dimethylhydrazine-induced pre-neoplastic lesions, oxidative stress and biotransforming enzymes, in an experimental model of rat colon carcinogenesis. Cell Prolif. 46 (2013), 705–720.
44. [44] Kharbanda, C., Sarwar Alam, M., Hamid, H., Bano, S., Haider, S., Nazreen, S., Ali, Y., Javed, K., Trapa natans L. root extract suppresses hyperglycemic and hepatotoxic effects in STZ-induced diabetic rat mode. J. Ethnopharmacol. 151 (2014), 931–936.